Table 3 Comparison between pre- and post-levetiracetam (group II) treatment regarding sex hormone assay and sperm parameters
Variable | Levetiracetam (group II) | P value | |
|---|---|---|---|
Pre-treatment | Post-treatment | ||
Sex hormones assay | |||
• Luteinizing hormone (LH) | 4.7 ± 2.0 | 3.7 ± 1.9 | 0.07 |
• Follicle-stimulating hormones (FSH) | 6.4 ± 3.16 | 5.1 ± 3.3 | 0.11 |
• Prolactin (PRL) | 8.65 ± 4.2 | 8.0 ± 3.6 | 0.12 |
• Testosterone (T) | 5.7 ± 1.6 | 5.0 ± 1.97 | 0.07 |
• Estradiol (E2) | 25.1 ± 11.7 | 24.6 ± 11.5 | 0.6 |
Sperm parameters | |||
• Concentration | 29.1 ± 12.6 | 23.2 ± 10.3 | 0.01* |
• Total count | 45.6 ± 9.1 | 38.8 ± 8.3 | 0.01* |
• Total motility | 57.96 ± 10.9 | 48.1 ± 12.3 | 0.001** |
• Normal morphology | 6.3 ± 1.8 | 5.1 ± 1.5 | 0.01* |